1. Home
  2. DENN vs ATYR Comparison

DENN vs ATYR Comparison

Compare DENN & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denny's Corporation

DENN

Denny's Corporation

HOLD

Current Price

$6.21

Market Cap

319.8M

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.71

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DENN
ATYR
Founded
1953
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.8M
79.2M
IPO Year
1989
2015

Fundamental Metrics

Financial Performance
Metric
DENN
ATYR
Price
$6.21
$0.71
Analyst Decision
Buy
Buy
Analyst Count
6
6
Target Price
$5.45
$8.75
AVG Volume (30 Days)
1.8M
2.0M
Earning Date
02-11-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$457,212,000.00
$190,000.00
Revenue This Year
$6.56
N/A
Revenue Next Year
$1.56
$18,728.88
P/E Ratio
$31.61
N/A
Revenue Growth
0.93
N/A
52 Week Low
$2.85
$0.64
52 Week High
$7.66
$7.29

Technical Indicators

Market Signals
Indicator
DENN
ATYR
Relative Strength Index (RSI) 65.36 39.46
Support Level $6.13 $0.69
Resistance Level $6.24 $0.76
Average True Range (ATR) 0.02 0.04
MACD -0.03 0.01
Stochastic Oscillator 57.14 15.75

Price Performance

Historical Comparison
DENN
ATYR

About DENN Denny's Corporation

Denny's Corp is America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees. Geographically operates in USA states as well as globally like Canada, Mexico, Guatemala, Indonesia, United Kingdom, New Zealand and others. Maximum revenue is from USA and Canada.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: